Over the past few decades, China emerged as the world’s largest exporter of antibiotic precursors. This helped to lower prices and keep costs under control in the healthcare system. But the global political uncertainty of recent years casts a new light on this strategy. “Germany is already heavily dependent on the Asian market for antibiotic production,” says Morris Hosseini, a partner at the consultancy Roland Berger.
Continue reading now
Get 30 days of free access to the Professional Briefing to read these and more quality news every day.
Are you already a guest at the China.Table? Log in now